Pe. Wandell et al., DRUG PRESCRIPTION IN DIABETIC-PATIENTS IN STOCKHOLM IN 1992 AND 1995 - CHANGE OVER TIME, European Journal of Clinical Pharmacology, 52(4), 1997, pp. 249-254
Objective: To describe and compare the distribution of prescribed drug
s in diabetic patients between 1992 and 1995. Methods: Two cross-secti
onal surveys of a random selection of medical records of diabetic pati
ents, from three community health centres (CHCs) in the Stockholm metr
opolitan area, were carried out. The age of the subjects ranged from 2
0 to 84 years. The number of prescriptions of pharmaceutical preparati
ons given to the diabetic patients was noted, as well as classificatio
n of the diabetes, the metabolic outcome, and concomitant hypertension
. Results: Between 1992 and 1995, the use of oral antidiabetics increa
sed significantly from 43 to 57% of the patients and the rate of treat
ment with diet only decreased from 30 to 20%. Combination treatment wi
th oral drugs and insulin rose significantly from 1 to 8% of the patie
nts. However, the greatest increase observed between 1992 and 1995 con
cerns cardiovascular drugs. The prescription rate of ACE inhibitors in
creased from 5 to 21%, of loop diuretics from 19 to 28%, of ASA from 9
to 21%, and of lipid-lowering agents from 1 to 7%. There was also a c
onsiderable variation between the three CHCs. Despite the more aggress
ive diabetic treatment strategies, the metabolic state was unchanged a
nd unsatisfactory for 40-50% of the patients. Conclusions: There have
been major changes towards more active pharmacological treatment regar
ding antidiabetic, cardiovascular, and lipid-lowering agents.